¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"granular layer of follicle of ovary"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary follicle
    ÀÏÂ÷³­Æ÷
  • primordial follicle
    ¿ø½Ã³­Æ÷
  • solitary follicle
    Ȭ¸²ÇÁ¼ÒÀý, °í¸³¸²ÇÁ¼ÒÀý
  • solitary lymphatic follicle
    Ȭ¸²ÇÁ¼ÒÀý, °í¸³¸²ÇÁ¼ÒÀý
  • sebaceous follicle
    ±â¸§»ùÁÖ¸Ó´Ï, ÇÇÁö»ùÁÖ¸Ó´Ï
  • basal layer
    ¹Ù´ÚÃþ, ±âÀúÃþ
  • buffy layer
    ¿¬Ãþ
  • circular layer
    µ¹¸²Ãþ
  • clear layer
    Åõ¸íÃþ
  • compact layer
    Ä¡¹ÐÃþ
  • cone cell layer
    ¿ø»Ô¼¼Æ÷Ãþ, ¿øÃß¼¼Æ÷Ãþ
  • cortical layer
    °ÑÁúÃþ, ÇÇÁúÃþ
  • cuticular layer
    ²®ÁúÃþ
  • cavernous layer
    ÇØ¸éÃþ
  • cambium layer
    Çü¼ºÃþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hair follicle
    ÅÐÁý, ÅÐÁÖ¸Ó´Ï, ¸ð³¶
  • lingual follicle
    Çô¸²ÇÁ¼ÒÀý
  • lymphatic follicle
    ¸²ÇÁ¼ÒÀý
  • mature follicle
    ¼º¼÷³­Æ÷
  • medullary follicle
    ¼ÓÁú³­Æ÷
  • primary follicle
    ÀÏÂ÷³­Æ÷
  • primordial follicle
    ¿ø½Ã³­Æ÷
  • sebaceous follicle
    ÇÇÁö»ùÁÖ¸Ó´Ï, ±â¸§»ùÁÖ¸Ó´Ï
  • solitary follicle
    °í¸³¸²ÇÁ¼ÒÀý, Ȭ¸²ÇÁ¼ÒÀý
  • solitary lymphatic follicle
    Ȭ¸²ÇÁ¼ÒÀý
  • tertiary ovarian follicle
    »ïÂ÷³­Æ÷
  • thyroid follicle
    °©»ó»ù¼ÒÆ÷, ¹æÆÐ»ù¼ÒÆ÷
  • agar layer method
    ¿ì¹«ÁßÃþ¹ý
  • basal layer
    ¹Ù´ÚÃþ
  • buffy layer
    ¿¬Ãþ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Graaf s follicle =G. vesicle
    ±×¶óÇÁ³­Æ÷.
  • Graaf s follicle =G. vesicle
    ±×¶óÇÁ³­Æ÷.
  • Graafian follicle
    ±×¶óÇÁ³­Æ÷(Õ°øà)
  • Hair follicle receptors
    ¸ð³¶¼ö¿ëü(Ù¾Ò¥â¥é»ô÷)
  • antral follicle
    µ¿³­Æ÷
  • antrum of ovarian follicle
    ³­Æ÷¹æ
  • germinal follicle
    ¹è¿©Æ÷(ÛÏæ¤øà).
  • graafian follicle
    ±×¶óÇÁ³­Æ÷(¡­Õ°øà).
  • graafian follicle
    ±×¶óÇÁ³­Æ÷(¡­Õ°øà).
  • growing follicle
    ¹ßÀ°³­Æ÷(Û¡ëÀÕ°øà).
  • hair follicle
    ÅÐÁÖ¸Ó´Ï
  • hair follicle ³ª folliculus pili
    ÅÐÁÖ¸Ó´Ï, ¸ð³¶(Ù¾Ò¥).
  • hair follicle ³ª folliculus pili
    ÅÐÁÖ¸Ó´Ï, ¸ð³¶(Ù¾Ò¥)
  • preantral follicle
    Àüµ¿³­Æ÷
  • preovulatory follicle
    ¹è¶õÀü ³­Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • descent of ovary
    ³­¼Ò³»¸²
  • hilus of ovary
    ³­¼Ò¹®
  • hilus of ovary <³ª>
    ³­¼Ò¹®(Õ°áµÚ¦).
  • interstitium of ovary
    ³­¼Ò»çÀÌÁú
  • large white ovary
    ´ë¹é³­¼Ò(ÓÞÛÜÕ°áµ).
  • ligament of ovary proper
    °íÀ¯³­¼ÒÁÖ¸§
  • lobulated ovary ³ª ovarium lobatum
    ºÐ¿±³­¼Ò(ÝÂç¨Õ°áµ).
  • medulla of ovary
    ³­¼Ò¼ÓÁú Ç÷°üÃþ
  • medulla of ovary
    ³­¼Ò¼ÓÁú
  • opened vaginal process of ovary
    ³­¼ÒÁýµ¹±â¿­¸²Áõ
  • ovary
    ³­¼Ò
  • ovary
    ³­¼Ò
  • ovary
    ³­¼Ò
  • ovary,streak
    ³­¼Ò»è(Ñëáµ»è), ³­¼Ò¼±(Ñëáµ¼±)
  • polycystic ovary
    ´Ù³¶³­¼Ò(¡­Õ°áµ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Antrum of ovarian follicle
    ³­Æ÷¹æ
    [¿¾ ¿ë¾î] ³­Æ÷µ¿
  • Stigma of ovarian follicle
    ¹è¶õÁ¡
    [¿¾ ¿ë¾î] ³­Æ÷¹®
  • Tertiary follicle
    »ïÂ÷³­Æ÷
    [¿¾ ¿ë¾î] »ïÂ÷³­Æ÷
  • Vesicular ovarian follicle
    »ïÂ÷³­Æ÷
    [¿¾ ¿ë¾î] Æ÷»ó³­Æ÷
  • Epithelial follicle
    »óÇÇÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] »óÇÇ¼ÒÆ÷
  • Medullary follicle
    ¼ÓÁú³­Æ÷
    [¿¾ ¿ë¾î] ¼öÁú³­Æ÷
  • Primordial cortical follicle
    ¿ø½Ã°ÑÁú³­Æ÷
    [¿¾ ¿ë¾î] ¿ø±âÇÇÁú³­Æ÷
  • Primordial follicle
    ¿ø½Ã³­Æ÷
    [¿¾ ¿ë¾î] ¿ø½Ã³­Æ÷
  • Primordial ovarian follicle
    ¿ø½Ã³­Æ÷
    [¿¾ ¿ë¾î] ¿ø½Ã³­Æ÷
  • Secondary follicle
    ÀÌÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­Æ÷
  • Secondary ovarian follicle
    ÀÌÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷³­Æ÷
  • Secondary hair follicle
    ÀÌÂ÷ÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷¸ð³¶
  • Primary follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ¿ø½Ã³­Æ÷
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
PCO Poly-Cystic Ovary
PCOD Poly-Cystic Ovary Disease
  = Stein-Leventhal Syndrome
PCOS Poly-Cystic Ovary(Ovarian) Syndrome
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CHO Chinese hamster ovary cell line
PCOS PolyCystic Ovary Syndrome
PCOD Polycystic Ovary Disease
PCO Polycystic Ovary Syndrome
PCO Polycystic ovary
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • interface layer
    °è¸éÃþ
  • layer
    Ãþ
    ½×Àº, °ãÄ£, Ä¥ÇÑ, µÎ²².
  • malpighian layer
    malpighi Ãþ
  • mantle layer
    ¿ÜÅõ Ãþ
  • molecular layer
    ºÐÀÚ Ãþ
  • mucous layer
    Á¡¾×Ãþ
  • nerve cell layer
    ½Å°æ ¼¼Æ÷ Ãþ
  • odondoblastic layer
    Á¶»ó¾Æ¼¼Æ÷ Ãþ
  • odontoblastic layer
    Á¶»ó¾Æ¼¼Æ÷Ãþ
  • papillary layer
    À¯µÎÃþ
    ÁøÇǰ¡ Ç¥ÇǸ¦ ¹Ð°í µé¾î°¡ »ý±ä ÁøÇÇ À¯µÎ¿Í Ç¥Çǰ¡ ÁøÇÇÂÊÀ¸·Î ¹Ð°í ³»·Á¿Í ¸¸µé¾îÁø Ç¥ÇÇ ´É¼± ¶Ç´Â Ç¥ÇÇ ½û±â·Î ±¸¼ºµÇ¾î ÀÖ´Ù.
  • phosphor layer
    ÀÎÃþ
  • plexiform layer
    ¾ó±â»ó Ãþ, ÃÑ»ó Ãþ
  • polished layer
    ¹ÙÀϺñÃþ
  • prickle cell layer
    ±Ø¼¼Æ÷ Ãþ, À¯±Ø ¼¼Æ÷Ãþ, °¡½ÃÃþ, À¯±ØÃþ
    ÀÎÁ¢ ¼¼Æ÷¿Í ¼¼Æ÷°£±³¸¦ Çü¼ºÇϰí ÀÖ´Â °¢È­ ±¸°­ »óÇÇÀÇ ÇÑ ¼¼Æ÷Ãþ.
  • prismless enamel layer
    ¹«Á¤Çü ¹ý¶ûÁúÃþ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
granular cast A relatively dark, dense urinary cast of coarsely or finely particulate cellular debris and other proteinaceous material, frequently seen in chronic renal disease but also in the recovery phase of acute renal failure.
See: waxy cast.
(05 Mar 2000)
granular cell tumour Unusual tumour affecting any site of the body, but most often encountered in the head and neck. Considerable debate has surrounded the histogenesis of this neoplasm; however, it is considered to be a myoblastoma of, usually, a benign nature. It affects women more often than men. When it develops beneath the epidermis or mucous membrane, it can lead to proliferation of the squamous cells and mimic squamous cell carcinoma.
(12 Dec 1998)
granular component of nucleolus Area of nucleolus that appears granular in the electron microscope and contains 15nm diameter particles that are maturing ribosomes. In contrast to the pale staining and fibrillar areas.
(18 Nov 1997)
granular conjunctivitis A chronic infection of the conjunctiva due to Chlamydia trachomatis, characterised by conjunctival follicles and subsequent cicatrization.
See: trachoma.
Synonym: granular conjunctivitis.
(05 Mar 2000)
granular cortex See: cerebral cortex.
(05 Mar 2000)
granular degeneration Swelling of cells due to injury to the membranes affecting ionic transfer; causes an accumulation of intracellular water.
Synonym: albuminous swelling, granular degeneration, hydropic degeneration, parenchymatous degeneration.
(05 Mar 2000)
granular endoplasmic reticulum Endoplasmic reticulum in which ribosomal granules are applied to the cytoplasmic surface of the cisternae; involved in the synthesis and secretion of protein via membrane-bound vesicles to the extracellular space.
Synonym: chromidial substance, ergastoplasm, rough-surfaced endoplasmic reticulum.
(05 Mar 2000)
granular kidney A kidney in which fairly uniform, diffusely and evenly situated foci of scarring of the interstitial tissue of the cortex (and sometimes scarring of glomeruli), and the associated slight degree of bulging of groups of dilated tubules, leads to the development of a minutely bosselated surface; such kidney's are seen in arteriolar nephrosclerosis or chronic glomerulonephritis.
Synonym: sclerotic kidney.
(05 Mar 2000)
granular layers of cerebral cortex Layers 2 (outer) and 4 (inner) of the cortex cerebri.
(05 Mar 2000)
granular layers of retina The outer nuclear layer, layer 4, of the retina, neuroepithelial layer of retina, and the inner layer, layer 6, of the retina, ganglionic layer of retina.
Synonym: granular layers of retina, stratum nucleare externum et internum retinae.
(05 Mar 2000)
granular leukoblast An obsolete term for promyelocyte.
(05 Mar 2000)
granular leukocyte Any one of the polymorphonuclear leukocyte's, especially a neutrophilic leukocyte.
See: granulocyte, basophilic leukocyte, eosinophilic leukocyte.
(05 Mar 2000)
granular lids <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
granular ophthalmia <ophthalmology> A chronic infectious disease of the conjunctiva and cornea, producing photophobia, pain, lacrimation and blindness.
It is one of the oldest infectious diseases known to mankind, and dates back several thousand years with first documentation as early as the pharaonic era in Egypt.
The disease is associated with poor socioeconomic conditions in general: with overcrowding, poor personal and environmental hygiene and, in particular, with very limited access to water and sanitation. Trachoma has been eliminated as a blinding disease from several previously hyperendemic countries and regions, both through significant improvements in the socioeconomic status of populations and through specific control efforts.
Despite these successes, in many least developed countries of the world blinding trachoma continues to be an important public health problem. In some of the countries where trachoma was once hyperendemic, there remain residual pockets of blinding trachoma and complications, such as inturned eyelashes (trichiasis), which require eyelid surgery.
Today, the disease is found mainly in poor rural areas, including parts of central and south America, most African countries and some countries in the Eastern Mediterranean. Trachoma is still endemic in several Asian countries, but there is a lack of updated information from some major populations, e.g. In India and China.
The organism that causes this disease is Chlamydia trachomatis; a microorganism resembling both bacteria and viruses, which spreads through contact with eye discharge from the infected person (on towels, handkerchiefs, fingers, etc.) and through transmission by eye-seeking flies. Chlamydia trachomatis provokes an inflammatory reaction in the eye with formation of follicles in the conjunctiva. After years of repeated infections, the inside of the eyelids may be scarred so severely that the eyelid turns inwards with eyelashes rubbing on the eyeball. If untreated, this condition leads to blindness.
The World Health Organization is working towards global elimination of trachoma, which is responsible, at present, for at least 15% of the world's blindness. Worldwide, there are about 6 million people largely irreversibly blinded by trachoma, and an estimated 146 million cases of active disease in need of treatment, if blindness is to be prevented.
International efforts to eliminate trachoma as a blinding disease will be based on a combination of interventions known by the acronym "SAFE", which stands for Surgery for trichiasis (inturned eyelashes), Antibiotics, Facial cleanliness and Environmental improvement. These interventions will be community-targeted and will seek community involvement through the primary health care approach.
Origin: Gr. Trachoma = roughness
(07 May 1998)
granular pits Pits on the inner surface of the skull, along the course of the superior sagittal sinus, in which are lodged the arachnoidal granulations.
Synonym: foveolae granulares, pacchionian depressions.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á